These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 22327923)

  • 1. 3-Tesla MR spectroscopy in patients subjected to bone marrow transplantation: clinical correlations.
    Sergiacomi G; Gaspari E; Taglieri A; Meschini A; Gisone V; Cudillo L; Arcese W; Simonetti G
    Radiol Med; 2013 Feb; 118(1):101-11. PubMed ID: 22327923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone marrow transplantation after failure of autologous transplant for non-Hodgkin's lymphoma.
    de Lima M; van Besien KW; Giralt SA; Khouri IF; Mehra R; Andersson BS; Przepiorka D; Gajewski JL; Korbling M; Champlin RE
    Bone Marrow Transplant; 1997 Jan; 19(2):121-7. PubMed ID: 9116608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allogeneic versus autologous bone marrow transplantation for refractory and recurrent low-grade non-Hodgkin's lymphoma.
    Verdonck LF; Dekker AW; Lokhorst HM; Petersen EJ; Nieuwenhuis HK
    Blood; 1997 Nov; 90(10):4201-5. PubMed ID: 9354692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allogeneic or autologous bone marrow transplantation (BMT) for non-Hodgkin's lymphoma (NHL): results of a provincial strategy. Ontario BMT Network, Canada.
    Schimmer AD; Jamal S; Messner H; Keating A; Meharchand J; Huebsch L; Walker I; Benger A; Gluck S; Smith A
    Bone Marrow Transplant; 2000 Oct; 26(8):859-64. PubMed ID: 11081385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of the composition of bone marrow prior to and following autologous BMT and PBSCT by magnetic resonance.
    Schick F; Einsele H; Weiss B; Forster J; Lutz O; Kanz L; Claussen CD
    Ann Hematol; 1996 Jun; 72(6):361-70. PubMed ID: 8767105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized study of erythropoietin and granulocyte colony-stimulating factor (G-CSF) versus placebo and G-CSF for patients with Hodgkin's and non-Hodgkin's lymphoma undergoing autologous bone marrow transplantation.
    Chao NJ; Schriber JR; Long GD; Negrin RS; Catolico M; Brown BW; Miller LL; Blume KG
    Blood; 1994 May; 83(10):2823-8. PubMed ID: 7514046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term follow-up of allogeneic bone marrow transplantation in patients with poor prognosis non-Hodgkin's lymphoma.
    Bernard M; Dauriac C; Drénou B; Leberre C; Branger B; Fauchet R; Le Prisé PY; Lamy T
    Bone Marrow Transplant; 1999 Feb; 23(4):329-33. PubMed ID: 10100576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hematopoietic reconstitution after bone marrow transplantation: assessment with MR imaging and H-1 localized spectroscopy.
    Schick F; Einsele H; Kost R; Duda S; Jung WI; Lutz O; Claussen CD
    J Magn Reson Imaging; 1994; 4(1):71-8. PubMed ID: 8148560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peripheral-blood stem-cell transplantation versus autologous bone marrow transplantation in Hodgkin's and non-Hodgkin's lymphomas: a new matched-pair analysis of the European Group for Blood and Marrow Transplantation Registry Data. Lymphoma Working Party of the European Group for Blood and Marrow Transplantation.
    Majolino I; Pearce R; Taghipour G; Goldstone AH
    J Clin Oncol; 1997 Feb; 15(2):509-17. PubMed ID: 9053472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gender and age groups interactions in the quantification of bone marrow fat content in lumbar spine using 3T MR spectroscopy: a multivariate analysis of covariance (Mancova).
    Roldan-Valadez E; Piña-Jimenez C; Favila R; Rios C
    Eur J Radiol; 2013 Nov; 82(11):e697-702. PubMed ID: 23938236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome in patients with myelodysplastic syndrome after autologous bone marrow transplantation for non-Hodgkin's lymphoma.
    Friedberg JW; Neuberg D; Stone RM; Alyea E; Jallow H; LaCasce A; Mauch PM; Gribben JG; Ritz J; Nadler LM; Soiffer RJ; Freedman AS
    J Clin Oncol; 1999 Oct; 17(10):3128-35. PubMed ID: 10506609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of venous thromboembolism in patients with non-Hodgkin lymphoma surviving blood or marrow transplantation.
    Gangaraju R; Chen Y; Hageman L; Wu J; Francisco L; Kung M; Ness E; Parman M; Weisdorf DJ; Forman SJ; Arora M; Armenian SH; Bhatia S
    Cancer; 2019 Dec; 125(24):4498-4508. PubMed ID: 31469420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome of relapsed non-Hodgkin's lymphoma patients after allogeneic and autologous transplantation.
    Vaishampayan U; Karanes C; Du W; Varterasian M; al-Katib A
    Cancer Invest; 2002; 20(3):303-10. PubMed ID: 12025224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proliferation and cytolytic function of anti-CD3 + interleukin-2 stimulated peripheral blood mononuclear cells following bone marrow transplantation.
    Katsanis E; Anderson PM; Filipovich AH; Hasz DE; Rich ML; Loeffler CM; Ochoa AC; Weisdorf DJ
    Blood; 1991 Sep; 78(5):1286-91. PubMed ID: 1831682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity of interleukin-2 in non-Hodgkin's lymphoma following transplantation of interleukin-2-activated autologous bone marrow or stem cells.
    van Besien K; Margolin K; Champlin R; Forman S
    Cancer J Sci Am; 1997 Dec; 3 Suppl 1():S54-8. PubMed ID: 9457395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Role of massive chemotherapy and bone marrow graft in the treatment of non-Hodgkin's lymphoma].
    Bouffet E; Favrot M; Biron P; Philip T
    Bull Cancer; 1990; 77(2):159-67. PubMed ID: 2180504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allogeneic bone marrow transplantation for relapsed and refractory Hodgkin's disease and non-Hodgkin's lymphoma.
    Dann EJ; Daugherty CK; Larson RA
    Bone Marrow Transplant; 1997 Sep; 20(5):369-74. PubMed ID: 9339751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone marrow transplantation in 46 pediatric patients with non-Hodgkin's lymphoma. Spanish Working Party for Bone Marrow Transplantation in Children.
    Bureo E; Ortega JJ; Muñoz A; Cubells J; Madero L; Verdaguer A; Baro J; Olivé T; Maldonado MS; Pardo N
    Bone Marrow Transplant; 1995 Mar; 15(3):353-9. PubMed ID: 7599558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring of chimerism after allogeneic bone marrow transplantation with unmanipulated marrow by use of DNA polymorphisms.
    Suttorp M; Schmitz N; Dreger P; Schaub J; Löffler H
    Leukemia; 1993 May; 7(5):679-87. PubMed ID: 8097800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T cell-depleted allogeneic bone marrow transplantation for high-risk non-Hodgkin's lymphoma: clinical and molecular follow-up.
    Juckett M; Rowlings P; Hessner M; Keever-Taylor C; Burns W; Camitta B; Casper J; Drobyski WR; Hanson G; Horowitz M; Lawton C; Margolis J; Peitryga D; Vesole D
    Bone Marrow Transplant; 1998 May; 21(9):893-9. PubMed ID: 9613781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.